Skip to main content

Non-dietary interventions for the treatment of anemia include a broad range of approaches including clinical interventions to treat individuals with anemia and other anemia-related conditions or broader public health programs. Non-dietary interventions to reduce anemia include prevention of and treatment for malaria, helminthiasis, tuberculosis, human immunodeficiency virus (HIV), acute or chronic blood loss, and hemolytic genetic disorders.

Malaria Prevention and Treatment

Malaria control in pregnancy and childhood can take many forms: intermittent preventive regimens in pregnant women through chemoprophylaxis with drugs such as sulfadoxine-pyrimethamine, prevention with use of long-lasting insecticide nets, use of environment vector control methods like indoor residual spraying, and prompt and accurate diagnosis of illness, followed appropriate use of effective anti-malarial drugs.

Deworming for Intestinal Parasites

Population-based deworming programs recommended for children over the age of one and pregnant women by WHO include mass drug administration, targeted chemotherapy, and selective therapy.

Treatment of Anemia of Inflammation Caused by Tuberculosis and HIV

The management of tuberculosis and HIV, the diagnosis and treatment approach to the associated anemia must include determination of etiology (e.g., differentiation between nutritional causes including iron deficiency and genetic hemoglobinopathies) to inform context specific, safe, and efficacious interventions.

Blood Transfusions

Women in Asia and sub-Saharan Africa have an increased risk of anemia from blood loss in the postpartum period compared to their counterparts in other regions of the world. Widespread adoption of comprehensive, evidence-based, up-to-date guidelines would need to effectively occur in the healthcare systems of the most affected populations to have a public health impact.  Blood transfusions used to correct the presence of anemia and have the potential to be lifesaving, particularly when loss of hemoglobin is acute, as in postpartum hemorrhage and with severe blood loss in trauma, shock, infections such as malaria, and other emergencies.

Delayed Cord Clamping

Immediate cord clamping at birth causes blood loss in newborns by as much as 25–35 mL per kilogram. World Health Organization guidelines recommend delayed umbilical cord clamping (not earlier than one minute after birth) for improved maternal and infant health outcomes, especially ferritin in the infants. This simple, inexpensive, and safe procedure is accepted as the standard of care for infants not requiring resuscitation.

Management of Inherited Red Blood Cell Disorders

Supportive care such as blood transfusions and pain medication have long been the mainstay of treatment and management of sickle cell anemia and its complications. Management of α- and β-thalassemia, and other transfusion-dependent anemias, is limited to supportive care, including chronic transfusion and iron-chelating therapy. Management of Glucose-6-phosphate dehydrogenase (G6PD) deficiency includes avoidance of known triggers (e.g., fava beans), widespread screening for the presence of G6PD deficiency, and in absence of widespread screening, the use of low dose primaquine for chemoprophylaxis of malaria endemic regions (to reduce population level risk of hemolysis in these individuals).

Limited data exists on the direct impact of the COVID-19 pandemic on nutritional status, beyond the obvious secondary effect on food insecurity, and the value of dietary/nutritional interventions, particularly in the context of anemia. As we all continue to learn from the impact of SARS-COV-2, we do not address COVID-19 in this toolkit.

Research has demonstrated the potential benefits of delayed cord clamping, deworming, anti-malaria treatment, and therapeutic clinical treatment such as blood transfusions as interventions to address the issue of anemia to varying degrees, in complex scenarios, and at times with conflicting evidence. Key factors that inhibit and motivate the desired behaviors should be considered and addressed through these interventions.

We found 17 resource(s)

Delaying Iron Therapy until 28 Days after Antimalarial Treatment Is Associated with Greater Iron Incorporation and Equivalent Hematologic Recovery after 56 Days in Children: A Randomized Controlled Trial
Journal Article published by Journal of Nutrition in
This randomized trial compares erythrocyte iron incorporation in 100 children in Mulago Hospital, Kampala, Uganda, who started iron supplementation either concurrently with antimalarial treatment or 28 days later.
Iron Deficiency Anaemia in Pregnancy: The Role of Parenteral Iron
Literature Review published by Journal of Obstetrics and Gynaecology in
This review presents evidence on the impact on maternal mortality of iron–folic acid supplementation from observational studies that were analyzed for the Global Burden of Disease analysis in 2004, and summarizes the evidence from other reviews on this topic.
Effect of Timing of Umbilical Cord Clamping of Term Infants on Maternal and Neonatal Outcomes
Systematic Review published by Cochrane Library in
This Cochhrane Systematic Review synthesizes the evidence on the effects of early cord clamping compared with late cord clamping on maternal and neonatal outcomes from 15 trials. The authors conclude that a more liberal approach to delaying clamping of the umbilical cord in healthy term infants appears to be warranted, particularly in light of…
Helminth Infections and Micronutrients in School-Age Children: A Systematic Review and Meta-Analysis
Systematic Review published by American Journal of Clinical Nutrition in
This systematic review synthesizes the evidence pertaining to the relationship of helminth infections with micronutrient status in school-age children worldwide, and concludes that evidence from observational studies and randomized controlled trials suggests distinct associations between helminth infections and micronutrients in school-age…
Pharmaceutical Management for Micronutrients and Anemia-Reduction Medicines
Presentation/Poster published by A2Z: The USAID Micronutrient and Child Blindness Project in
This presentation from the Manoff Group highlights supply chain considerations, from a pharmaceutical perspective, for medicines and supplements aimed at supplying micronutrients and combating anemia.
Iron Interventions for Women and Children in Low-Income Countries
Literature Review published by The Journal of Nutrition in
This review highlights how iron interventions might be positioned within four global health initiatives: making pregnancy safer, saving newborn lives, infant and young child feeding, and fortification.
National Strategy for Anaemia Prevention and Control in Bangladesh
Technical Report published by National Strategy for Anemia Prevention and Control in
This National Strategy aimed to reduce the prevalence of anemia among high-risk groups in Bangladesh by 2015 by 25 percent. The strategy identifies comprehensive interventions aimed at high-risk groups, in particular infants and young children, adolescent girls, newly wed women, and pregnant and breastfeeding women.
Late vs. Early Clamping of the Umbilical Cord in Full-Term Neonates: Systematic Review and Meta-Analysis of Controlled Trials
Systematic Review published by in
This systematic review synthesizes the evidence pertaining to benefits and risks with regard to timing of umbilical cord clamping in full-term neonates.